Recently body fluids including liquid biopsy, circulating tumour cells, cell-free nucleic acid, circulating tumour DNA, and carcinoembryonic antigen have been investigated for developing new biomarkers in GC [28–30]. Here, CEACAM5 is linked to neoplasm.